Seattle, WA, United States of America

Pascal Beauchesne

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Pascal Beauchesne in Immune Cell Therapy

Introduction

Pascal Beauchesne is a notable inventor based in Seattle, WA (US), recognized for his contributions to the field of immune cell therapy. With a total of five patents to his name, he has made significant strides in the methods of isolating, culturing, and genetically engineering immune cell populations for adoptive therapy.

Latest Patents

One of his latest patents focuses on methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy. This patent discloses streamlined cell preparation methods that enhance the efficiency of isolating, processing, incubating, and genetically engineering cells. The methods are designed to prepare various cell populations for adoptive therapy using fewer steps and resources compared to traditional methods. Another significant patent involves a process for generating therapeutic compositions of engineered cells. This patent outlines methods for genetically engineering T cells, particularly CD4+ T cells, for use in cell therapy. The methods include incubating the cells under stimulating conditions and introducing recombinant polypeptides through transduction or transfection, promoting cell proliferation and expansion.

Career Highlights

Pascal Beauchesne is currently associated with Juno Therapeutics GmbH, where he continues to innovate in the field of cell therapy. His work has been pivotal in advancing the understanding and application of genetically engineered T cells in therapeutic settings.

Collaborations

He collaborates with esteemed colleagues such as Mark L Bonyhadi and Chris Ramsborg, contributing to a dynamic research environment that fosters innovation in immune cell therapies.

Conclusion

Pascal Beauchesne's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immune cell therapy. His patents and ongoing research are paving the way for more effective treatments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…